Search research articles
Contact Us
Filters
Showing results (21-30 of 36) with videos related to
Page
of 4
Sort By:
Frontiers in Oncology
|
October 24, 2022
Enhanced lipid metabolism confers the immunosuppressive tumor microenvironment in CD5-positive non-MYC/BCL2 double expressor lymphoma
Meng-Ke Liu, Li-Li Cheng, Hong-Mei Yi, et al.
Blood
|
May 21, 2026
N6-methyladenosine reader IGF2BP2 in T-cell lymphoma
Song Hu, Yao Qin, Hong-Mei Yi, et al.
Oncotarget
|
August 29, 2015
MiR-23a sensitizes nasopharyngeal carcinoma to irradiation by targeting IL-8/Stat3 pathway
Jia-Quan Qu, Hong-Mei Yi, Xu Ye, et al.
Blood Advances
|
January 3, 2024
Biological signatures of the International Prognostic Index in diffuse large B-cell lymphoma
Yue Wang, Qing Shi, Zi-Yang Shi, et al.
Molecular Cancer Therapeutics
|
August 26, 2015
MiRNA-203 Reduces Nasopharyngeal Carcinoma Radioresistance by Targeting IL8/AKT Signaling
Jia-Quan Qu, Hong-Mei Yi, Xu Ye, et al.
International Journal of Biological Sciences
|
August 8, 2024
<i>KMT2D</i> mutations promoted tumor progression in diffuse large B-cell lymphoma through altering tumor-induced regulatory T cell trafficking via FBXW7-NOTCH-MYC/TGF-β1 axis
Qing-Xiao Liu, Yue Zhu, Hong-Mei Yi, et al.
Blood
|
February 27, 2026
CSNK1E Sustains Stem-like Drug Persistence in Diffuse Large B-cell Lymphoma
Xiang Li, Mengke Liu, Qing Shi, et al.
Signal Transduction and Targeted Therapy
|
March 6, 2024
Anti-metabolic agent pegaspargase plus PD-1 antibody sintilimab for first-line treatment in advanced natural killer T cell lymphoma
Jie Xiong, Shu Cheng, Xiao Gao, et al.
Genome Medicine
|
October 24, 2025
Clinical characteristics and molecular heterogeneity in Follicular lymphoma with extranodal involvement
Rui-Chi Li, Wei Tang, Hui-Lai Zhang, et al.
Cancer Cell
|
September 29, 2023
Genetic subtype-guided immunochemotherapy in diffuse large B cell lymphoma: The randomized GUIDANCE-01 trial
Mu-Chen Zhang, Shuang Tian, Di Fu, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 36) with videos related to
Sort By:
Page
of 4
Frontiers in Oncology
|
October 24, 2022
Enhanced lipid metabolism confers the immunosuppressive tumor microenvironment in CD5-positive non-MYC/BCL2 double expressor lymphoma
Meng-Ke Liu, Li-Li Cheng, Hong-Mei Yi, et al.
Blood
|
May 21, 2026
N6-methyladenosine reader IGF2BP2 in T-cell lymphoma
Song Hu, Yao Qin, Hong-Mei Yi, et al.
Oncotarget
|
August 29, 2015
MiR-23a sensitizes nasopharyngeal carcinoma to irradiation by targeting IL-8/Stat3 pathway
Jia-Quan Qu, Hong-Mei Yi, Xu Ye, et al.
Blood Advances
|
January 3, 2024
Biological signatures of the International Prognostic Index in diffuse large B-cell lymphoma
Yue Wang, Qing Shi, Zi-Yang Shi, et al.
Molecular Cancer Therapeutics
|
August 26, 2015
MiRNA-203 Reduces Nasopharyngeal Carcinoma Radioresistance by Targeting IL8/AKT Signaling
Jia-Quan Qu, Hong-Mei Yi, Xu Ye, et al.
International Journal of Biological Sciences
|
August 8, 2024
<i>KMT2D</i> mutations promoted tumor progression in diffuse large B-cell lymphoma through altering tumor-induced regulatory T cell trafficking via FBXW7-NOTCH-MYC/TGF-β1 axis
Qing-Xiao Liu, Yue Zhu, Hong-Mei Yi, et al.
Blood
|
February 27, 2026
CSNK1E Sustains Stem-like Drug Persistence in Diffuse Large B-cell Lymphoma
Xiang Li, Mengke Liu, Qing Shi, et al.
Signal Transduction and Targeted Therapy
|
March 6, 2024
Anti-metabolic agent pegaspargase plus PD-1 antibody sintilimab for first-line treatment in advanced natural killer T cell lymphoma
Jie Xiong, Shu Cheng, Xiao Gao, et al.
Genome Medicine
|
October 24, 2025
Clinical characteristics and molecular heterogeneity in Follicular lymphoma with extranodal involvement
Rui-Chi Li, Wei Tang, Hui-Lai Zhang, et al.
Cancer Cell
|
September 29, 2023
Genetic subtype-guided immunochemotherapy in diffuse large B cell lymphoma: The randomized GUIDANCE-01 trial
Mu-Chen Zhang, Shuang Tian, Di Fu, et al.
Page
of 4